EPISODE · Aug 25, 2025 · 12 MIN
New Guidelines for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Rethinking Hematopoietic Stem Cell Transplantation
from MS MASTERS · host Practical Neurology
Jeffrey Cohen, MD, Professor, Cleveland Clinic Lerner College of Medicine, and Director of the Experimental Therapeutics Program at the Mellen Center for Multiple Sclerosis Treatment and Research at Cleveland Clinic, Cleveland, OH, reviews the latest international guidelines from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and EBMT on the use of autologous hematopoietic stem cell transplantation (AHSCT) in relapsing multiple sclerosis and neuromyelitis optica spectrum disorder.
NOW PLAYING
New Guidelines for Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: Rethinking Hematopoietic Stem Cell Transplantation
No transcript for this episode yet
Similar Episodes
Feb 2, 2025 ·51m
Jan 20, 2025 ·49m
Dec 23, 2024 ·66m
Dec 2, 2024 ·61m